A study team that first opened its recruitment in southern Indiana earlier this year has seen remarkable growth in patient enrollment over the last eight months.
Precision Health News
In the last month, the IU Precision Health Initiative has been in the news for several different projects, such as COVID-19 testing and mitigation, COVID-19 Long Hauler symptoms, the new IBRI CEO, and racial health disparities.
The Undiagnosed and Rare Disease Clinic (URDC) launched in January 2020 and has already seen success. Researchers affiliated with the clinic help patients who may have genetically-based rare diseases, when other doctors have not been able to determine a diagnosis.
In the last month, the IU Precision Health Initiative has been in the news for several different projects, such as COVID-19 "Long Hauler" symptoms, health information exchanges, triple negative breast cancer research, and a new saliva test for COVID-19.
Natalie Lambert, PhD, associate research professor at IU School of Medicine, is studying COVID-19 “Long Hauler” symptoms. People who consider themselves to be “Long Haulers” can suffer from symptoms for weeks or months after being diagnosed with COVID-19. Lambert’s most recent research involves a study she conducted in partnership with Survivor Corps, a nonprofit group for people who have been affected by COVID-19 which encourages them to participate in medical and scientific research.
In the last month, the IU Precision Health Initiative has been in the news for several different projects, such as breast cancer research, how the novel coronavirus spreads, and just how many symptoms COVID-19 "Long Haulers" can have for weeks or months after contracting the disease.
Since its inception, the IU Grand Challenge Precision Health Initiative (PHI) has not only been about discovering better treatments, cures and ways to prevent some of the state’s most devastating diseases – its also been about educating the next generation of researchers and health care providers – on how to use some of PHI’s most powerful tools, such as genetics, genomics, and informatics, to improve the health of patients.
Researchers are restarting the communications campaign to recruit patients for the National Cancer Institute-sponsored clinical trial, EAZ171, a unique study looking at Black women with breast cancer. The goal of this study is to help doctors better understand and treat Black breast cancer patients with neuropathy, which is a side effect from chemotherapy.
In the last month, the IU Precision Health Initiative has been in the news for several different research projects.